An‐Wen Chan

43.5k citations

128 papers · 11.5k indexed · 4 hit papers · h-index 34

Impact in

Statistics, Probability and Uncertainty top 0.02%
- Meta-analysis and systematic reviews
Health Informatics top 0.5%

Papers in

Statistics, Probability and Uncertainty 58
- Meta-analysis and systematic reviews 58
Health Informatics 3

Co-authors: Douglas G. Altman Peter C Gøtzsche Asbjørn Hróbjartsson Kay Dickersin David Moher Jennifer Tetzlaff Mette T. Haahr Karmela Krleža-Jerić
Journals: Trials (9 papers)Journal of Clinical Epidemiology (7 papers)BMJ Open (7 papers)Journal of Investigative Dermatology (6 papers)The Lancet (5 papers)
Partner nations: Canada United Kingdom United States

In The Last Decade

An‐Wen Chan

118 papers receiving 11.2k citations

Hit Papers

align trajectories log scale

Increasing value and reducing waste: addressing inaccessible research 2014 · 536 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2014 The Lancet
2013 Annals of Internal Medicine
2008 PLoS ONE
2004 JAMA

Peers

Countries citing papers authored by An‐Wen Chan

Since Specialization

Citations

This map shows the geographic impact of An‐Wen Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by An‐Wen Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites An‐Wen Chan more than expected).

Fields of papers citing papers by An‐Wen Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by An‐Wen Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by An‐Wen Chan. The network helps show where An‐Wen Chan may publish in the future.

Co-authors

The 25 scholars most cited alongside An‐Wen Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with An‐Wen Chan Line = papers co-authored together An‐Wen Chan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Reporting summary results in clinical trial registries: updated guidance from WHO The Lancet Global Health ·An‐Wen Chan, Ghassan Karam, Meilinda Rifka Novita, Lisa Askie, Thu Diem Le, Ségolène Aymé, Colman Taylor, Lotty Hooft, Anna Laura Ross, Vasee Moorthy	2025	5
2	Scoping review of registration of observational studies finds inadequate registration policies, increased registration, and a debate converging toward proregistration Journal of Clinical Epidemiology ·Roethel Hans K., M. Narwojsz, E. R., Yu. Yu. Fyodorov, M. Kaupenjohann, An‐Wen Chan, Asbjørn Hróbjartsson	2025	1
3	Incidence, mortality and survival of Merkel cell carcinoma: a systematic review of population-based studies British Journal of Dermatology ·David Salom Alonso, Villavicencio Almeida, An‐Wen Chan, Timothy P. Hanna, James J. Limacher, Carolyn Nessim, Melvin I. Polhl, Victor A. Tron, Frances C. Wright, Aaron M. Drucker	2023	19
4	Definitions, acceptability, limitations, and guidance in the use and reporting of surrogate end points in trials: a scoping review Journal of Clinical Epidemiology ·Anthony Muchai Manyara, Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Valerie Wells, Jane Blazeby, Nancy J. Butcher, Sylwia Bujkiewicz, An‐Wen Chan, Gary S. Collins, Dalia Dawoud, Martin Offringa, Mario Ouwens, Joseph S. Ross, Rod S Taylor, Oriana Ciani	2023	12
5	Evaluating prospective study registration and result reporting of trials conducted in Canada from 2009 to 2019 FACETS ·J. Puig, Kelly D. Cobey, Jeremy Y. Ng, Clare L. Ardern, Karim Khan, An‐Wen Chan, 최미순, Mouayad Masalkhi, Ana Patricia Ayala, Sanam Ebrahimzadeh, A. Da Vies, Chanya Deekiatphaiboon, Y.H. Kim, David Moher	2023	7
6	Protocol for the development of SPIRIT and CONSORT extensions for randomised controlled trials with surrogate primary endpoints: SPIRIT-SURROGATE and CONSORT-SURROGATE BMJ Open ·Anthony Muchai Manyara, Philippa Davies, Derek Stewart, Christopher J. Weir, Amber Young, Nancy J. Butcher, Sylwia Bujkiewicz, An‐Wen Chan, Gary S. Collins, Dalia Dawoud, Martin Offringa, Mario Ouwens, Joseph S. Ross, Rod S Taylor, Oriana Ciani	2022	12
7	Noninferiority Randomized Controlled Trials Journal of Investigative Dermatology ·Kevin Kim, An‐Wen Chan, Emilie P. Belley‐Côté, Aaron M. Drucker	2022	4
8	Picosecond Infrared Laser Mass Spectrometry Identifies a Metabolite Array for 10 s Diagnosis of Select Skin Cancer Types: A Proof-of-Concept Feasibility Study Analytical Chemistry ·Terutaka Watanbe, Michael Woolman, Taira Kiyota, Layla Pires, Mark Zaidi, Stefan O.P. Hofer, Wey L. Leong, Bradly G. Wouters, Danny Ghazarian, An‐Wen Chan, Howard J. Ginsberg, Asma M. Aman, Brian C. Wilson, Hal K. Berman, Arash Zarrine‐Afsar	2022	10
9	Gender disparity between authors in leading medical journals during the COVID-19 pandemic: a cross-sectional review BMJ Open ·Olga Koruniak, L. Raichuk, Luqman Dzul Hilmi, Wei Wu, Robín Masón, An‐Wen Chan, Paula A. Rochon, Iliana C. Lega, Husam Abdel‐Qadir	2021	25
10	Selective outcome reporting across psychopharmacotherapy randomized controlled trials International Journal of Methods in Psychiatric Research ·裕亮田口, 上岡克嘉, Joeri K. Tijdink, An‐Wen Chan, Christiaan H. Vinkers, Jurjen J. Luykx	2021	6
11	Development Protocol: CONSORT and SPIRIT Extension for RCTs reVised in Extenuating Circumstances OSF Preprints (OSF Preprints) ·Philipp Krop, Maja Karoline Rynning, Aaron Orkin, An‐Wen Chan, Peter Jüni	2021	0
12	A scoping review of outcome-reporting recommendations for clinical trial protocols and reports OSF Preprints (OSF Preprints) ·Nancy J. Butcher, Andrea Monsour, David Moher, Martin Offringa, Emma J. Mew, An‐Wen Chan	2019	2
13	Instrument for reporting Planned Endpoints in Clinical Trials (InsPECT) OSF Preprints (OSF Preprints) ·David Moher, Martin Offringa, Andrea Monsour, Emma J. Mew, An‐Wen Chan, (unknown), Nancy J. Butcher	2018	3
14	Improved keratinocyte carcinoma outcomes with annual dermatology assessment after solid organ transplantation: Population-based cohort study American Journal of Transplantation ·An‐Wen Chan, Kinwah Fung, Peter C. Austin, Soojin Kim, L.G. Singer, Nancy N. Baxter, Raed Alhusayen, Paula A. Rochon	2018	27
15	Search for unpublished data by systematic reviewers: an audit BMJ Open ·Hedyeh Ziai, Горбатовская Людмила Михайловна, An‐Wen Chan, Nav Persaud	2017	26
16	Association of Trial Registration With Reporting of Primary Outcomes in Protocols and Publications WOS ·An‐Wen Chan, Bojan Barišić, Hongyi Ma, Andreza Silva, Jorma I. Virtanen, Jiaxi Yang, Elina Hemminki	2017	1
17	Comprehensive capture of cutaneous melanoma by the Ontario Cancer Registry: validation study using community pathology reports Cancer Causes & Control ·Jennifer M. Tran, Florence Gemignani, Kinwah Fung, Paula A. Rochon, An‐Wen Chan	2015	18
18	Interventions for melanoma in situ, including lentigo maligna Cochrane Database of Systematic Reviews ·Thrasyvoulos Tzellos, Αthanassios Kyrgidis, Simone Mocellin, An‐Wen Chan, Pierluigi Pilati, Zoé Apalla	2014	49
19	Better reporting of interventions: Template for intervention description and replication (TIDieR) checklist and guide UCL Discovery (University College London) ·Tammy Hoffmann, Paul Glasziou, Isabelle Boutron, Ruairidh Milne, Rafael Perera, David Moher, Douglas G. Altman, Virginia Barbour, Helen Macdonald, Marie Johnston, Sarah E Lamb, Mary Dixon‐Woods, Peter McCulloch, Jeremy C Wyatt, An‐Wen Chan, Susan Michie	2014	4
20	Inadequate Dissemination of Phase I Trials: A Retrospective Cohort Study PLoS Medicine ·Évelyne Decullier, An‐Wen Chan, François Chapuis	2009	28

About An‐Wen Chan

An‐Wen Chan is a scholar working on Statistics, Probability and Uncertainty, Health Informatics, Statistics and Probability, Dermatology and Economics and Econometrics, having authored 128 papers that have together received 11.5k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (58 papers), Health Systems, Economic Evaluations, Quality of Life (42 papers), Ethics in Clinical Research (22 papers), Nonmelanoma Skin Cancer Studies (22 papers), Delphi Technique in Research (19 papers), Statistical Methods in Clinical Trials (17 papers), Cutaneous Melanoma Detection and Management (15 papers) and Pharmaceutical industry and healthcare (12 papers). The work is most often cited by research in Statistics, Probability and Uncertainty (3.2k citations), Health Informatics (199 citations), Statistics and Probability (794 citations), Public Health, Environmental and Occupational Health (2.6k citations) and Pharmacology (672 citations). An‐Wen Chan has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Douglas G. Altman, Peter C Gøtzsche, Asbjørn Hróbjartsson, Kay Dickersin, David Moher, Jennifer Tetzlaff, Mette T. Haahr, Karmela Krleža-Jerić, Kenneth F. Schulz and Wendy R. Parulekar. Their work appears in journals such as Trials, Journal of Clinical Epidemiology, BMJ Open, Journal of Investigative Dermatology and The Lancet.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact